Nobody Thought It Would Come to This': Drug Maker Teva Faces a Crisis - The New York Times
Teva: Warren Buffett Likely Made A Mistake Selling Shares | Seeking Alpha
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Teva reaches $523 million deal to settle opioid lawsuit with New York | CNN Business
Nobody Thought It Would Come to This': Drug Maker Teva Faces a Crisis - The New York Times
Teva sells its only manufacturing plant in Russia
Nobody Thought It Would Come to This': Drug Maker Teva Faces a Crisis - The New York Times
Teva Pharmaceuticals Found Liable For Opioid Crisis by Jury, Trial Will Determine Penalty
Teva Pays $420 Million to End Generic-Drug Securities Suit (1)
Teva Reports First Quarter 2020 Financial Results | Business Wire
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Teva Pharmaceutical Stock: Prepare For Takeoff (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical Stock: Prepare For Takeoff (NYSE:TEVA) | Seeking Alpha
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Teva to pay New York $500M for role in opioid crisis - POLITICO
Teva reaches $4.25B deal to settle opioid lawsuits | The Hill
Nobody Thought It Would Come to This': Drug Maker Teva Faces a Crisis - The New York Times
Teva sees return to growth after opioid settlement, shares jump | Reuters
Teva shares surge after announcing global opioid settlement
Teva puts further $468m aside for opioid settlements | Financial Times
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
Teva Avoids Bankruptcy, Huge Upside (NYSE:TEVA) | Seeking Alpha
Will Teva Stock Rebound After A 10% Fall In A Month?
Teva Stock Skyrockets After Inking North Of $4 Billion In Opioid Settlements | Investor's Business Daily
Teva Finds Relief In US Opioid Crisis Settlement, Updates Long-Term Objectives :: Scrip
